SANGAMO THERAPEUTICS, INC. (SGMOQ) Capital expenditures 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$102,000FY2025 · since FY2016: $732,000 → $102,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $102,000 | -61.8% |
| FY2024 | $267,000 | -98.7% |
| FY2023 | $21.2M | +4.9% |
| FY2022 | $20.2M | -13.3% |
| FY2021 | $23.3M | +58.2% |
| FY2020 | $14.7M | -28.8% |
| FY2019 | $20.7M | -52.0% |
| FY2018 | $43.1M | +1048.1% |
| FY2017 | $3.8M | +412.4% |
| FY2016 | $732,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice